Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. (Q47572013)

4 February 2018

title

Amyloid β concentrations and stable isotope labeling kinetics of human plasma specific to central nervous system amyloidosis. (English)

1 reference

4 February 2018

1 reference

9

David M Holtzman

1 reference

4 February 2018

12

Anne M Fagan

1 reference

4 February 2018

13

Bruce W Patterson

1 reference

4 February 2018

Tammie L. Benzinger

11

Tammie Benzinger

1 reference

4 February 2018

John C. Morris

10

John C Morris

1 reference

4 February 2018

Randall J. Bateman

14

Randall J Bateman

1 reference

4 February 2018

Kwasi G. Mawuenyega

3

Kwasi G Mawuenyega

1 reference

4 February 2018

Vitaliy Ovod

1

Vitaliy Ovod

1 reference

4 February 2018

Katrina L Paumier

8

Katrina Paumier

1 reference

4 February 2018

author name string

Kara N Ramsey

2

1 reference

4 February 2018

Jim G Bollinger

4

1 reference

4 February 2018

Terry Hicks

5

1 reference

4 February 2018

Theresa Schneider

6

1 reference

4 February 2018

Melissa Sullivan

7

1 reference

4 February 2018

publication date

11 July 2017

1 reference

4 February 2018

published in

Alzheimer's and Dementia

1 reference

4 February 2018

volume

13

1 reference

4 February 2018

issue

8

1 reference

4 February 2018

page(s)

841-849

1 reference

4 February 2018

The amyloid hypothesis of Alzheimer's disease at 25 years

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Age and amyloid effects on human central nervous system amyloid-beta kinetics

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Amyloid-β efflux from the central nervous system into the plasma

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Early detection of Alzheimer's disease using PiB and FDG PET

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Increased in vivo amyloid-β42 production, exchange, and loss in presenilin mutation carriers

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Amyloid-beta isoform metabolism quantitation by stable isotope-labeled kinetics

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Accuracy of the clinical diagnosis of Alzheimer disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Association of plasma beta-amyloid level and cognitive reserve with subsequent cognitive decline

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Plasma levels of alpha beta peptides are altered in amnestic mild cognitive impairment but not in sporadic Alzheimer's disease.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

High cerebrospinal fluid tau and low amyloid beta42 levels in the clinical diagnosis of Alzheimer disease and relation to apolipoprotein E genotype.

26 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5567785

Plasma A[beta]40 and A[beta]42 and Alzheimer's disease: relation to age, mortality, and risk

26 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28734653

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1016/J.JALZ.2017.06.2266

1 reference

4 February 2018

0 references

1 reference

4 February 2018